China Universal Asset Management Co., Ltd. Biocryst Pharmaceuticals Inc Transaction History
China Universal Asset Management Co., Ltd.
- $893 Million
- Q3 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 39,791 shares of BCRX stock, worth $302,411. This represents 0.03% of its overall portfolio holdings.
Number of Shares
39,791
Previous 24,247
64.11%
Holding current value
$302,411
Previous $149,000
102.68%
% of portfolio
0.03%
Previous 0.02%
Shares
14 transactions
Others Institutions Holding BCRX
# of Institutions
279Shares Held
172MCall Options Held
625KPut Options Held
739K-
Vanguard Group Inc Valley Forge, PA20.3MShares$154 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$152 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.9MShares$90.2 Million1.36% of portfolio
-
Kynam Capital Management, LP Princeton, NJ9.09MShares$69 Million5.66% of portfolio
-
State Street Corp Boston, MA8.85MShares$67.3 Million0.0% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.41B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...